Sam Lidman: Daily
A masterclass in identifying the trends and companies that stand the test of time.
SL
Editor
Sam Lidman
About This Column
Sam Lidman is a commentator and strategist who explores the intersection of performance and permanence. Transitioning from his deep dive into defensive investing, Sam now delivers daily dispatches on the broad forces driving consistent value creation in the 21st century. With a reputation for looking beneath surface-level volatility, he offers a unique lens on how businesses and industries navigate headwinds with strength. His writing is essential reading for anyone seeking to understand the mechanics of resilience and the identifying marks of a winner in an unpredictable global landscape.
Displaying items 621-640 of 797 in total
Read full article
New At-Home Device Targets Escalating PAD Health Crisis
Read full article
Lightship Acquires Veda, Bringing Clinical Trials to Local Clinics
Read full article
Coder and WWT Partner to Secure Enterprise AI Development at Scale
Read full article
Three Link Deepens Workday Tie-Up, Boosting Enterprise Innovation
Read full article
Race for Scarborough Southwest Begins After Bill Blair's Resignation
Read full article
Cardiology's Malpractice Minefield: New Report Reveals Top Risks
Read full article
ClimateTech Connect Unites Insurers Against Escalating Climate Risk
Read full article
EP Wealth Acquires B Corp Pioneer LongView in Southwest Expansion
Read full article
New Bill Offers Vets Access to Novel Therapies, Including MEAI
Read full article
Beyond the Wipe: BitRaser Tackles Costly Device Lock-In Problem
Read full article
Maestra's Growth Surge Challenges Klaviyo's DTC Marketing Reign
Read full article
FDA Grants Breakthrough Status to Novel Breast Cancer Drug Zovegalisib
Read full article
Australia's Public Sector AI Boom Hindered by Digital Fragmentation
Read full article
Atlantic Taps New CFO to Steer $1.2B Post-Acquisition Strategy
Read full article
PointsKash Taps Plaid to Fortify Its Unified Payments Platform
Read full article
Alcon's PRECISION7 Aims to Disrupt the Canadian Contact Lens Market
Read full article
Blood Test Revolutionizes Post-Surgery Colon Cancer Care
Read full article
Nada's $150M Deal Signals a Boom for Debt-Free Home Equity Access
Read full article
Biodegradable Sensors Offer Dual Fix for E-Waste and Air Pollution
Read full article
UCID: 23
